HIV expenditure on prevention and treatment in Algeria
Algeria: HIV expenditure on prevention and treatment was 31.90 million constant 2019 US$ in 2017. ◆ Volatile
HIV expenditure on prevention and treatment in Algeria, 2006–2017
Source: Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Measured in constant 2019 US$.
Analysis
In 2017, hiv expenditure on prevention and treatment in Algeria stood at 31.90 million constant 2019 US$. That is the highest value across all 9 years on record.
The figure is up 84.7% on the previous year and up 768.3% over ten years.
Over the whole period, hiv expenditure on prevention and treatment in Algeria peaked at 31.90 million constant 2019 US$ in 2017 and was at its lowest, 2.73 million constant 2019 US$, in 2009.
Algeria ranks 41st of 144 countries on this measure, in the middle of the range.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3.40 million constant 2019 US$ | 2.73 million constant 2019 US$ | 3.80 million constant 2019 US$ | 3 |
| 2010s | 13.43 million constant 2019 US$ | 5.84 million constant 2019 US$ | 31.90 million constant 2019 US$ | 6 |
Countries ranked near Algeria
- 38 Uzbekistan 32.92 million constant 2019 US$ compare
- 39 Togo 32.92 million constant 2019 US$ compare
- 40 Kuwait 32.38 million constant 2019 US$ compare
- 42 Cambodia 31.57 million constant 2019 US$ compare
- 43 Guinea 27.77 million constant 2019 US$ compare
- 44 Central African Republic 27.11 million constant 2019 US$ compare
More health data for Algeria
- Estimated changes in temperature-related death rates compared to projected death rates 943.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,455 deaths (2100)
- Deaths in armed conflicts based on where they occurred 0 deaths (2026)
- Deaths in armed conflicts by region 0 deaths (2026)
- Age population, age 25, male, interpolated 283,673 (2025)
- Age population, age 25, female, interpolated 275,275 (2025)
- Age population, age 24, male, interpolated 288,536 (2025)
- Age population, age 24, female, interpolated 279,016 (2025)
- Age population, age 23, male, interpolated 290,087 (2025)
- Age population, age 23, female, interpolated 279,694 (2025)
Frequently asked questions
- What is hiv expenditure on prevention and treatment in Algeria?
- Hiv expenditure on prevention and treatment in Algeria was 31.90 million constant 2019 US$ in 2017, according to Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data.
- What is the highest hiv expenditure on prevention and treatment recorded in Algeria?
- The highest recorded value was 31.90 million constant 2019 US$ in 2017.
- What is the lowest hiv expenditure on prevention and treatment recorded in Algeria?
- The lowest recorded value was 2.73 million constant 2019 US$ in 2009.
- How does Algeria rank for hiv expenditure on prevention and treatment?
- Algeria ranks 41st out of 144 countries with data for 2017.
- Is hiv expenditure on prevention and treatment rising or falling in Algeria?
- Over the last ten years it is up 768.3%. The long-run trend across the full record is volatile.
- Where does this Algeria data come from?
- The figures come from Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as part of HIV expenditure on prevention and treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 9 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Total in-country spending on HIV programs and services.